| Line Item | 2024-10-31 | Y/Y |
|---|---|---|
| Revenue | $6.51B | -4.7% |
| Cost of Revenue | $2.98B | -11.7% |
| R&D Expense | $479.0M | -0.4% |
| SG&A Expense | $1.57B | -4.0% |
| Operating Income | $1.49B | +10.2% |
| Interest Expense | $96.0M | +1.1% |
| Pre-tax Income | $1.52B | +13.6% |
| Income Tax | $232.0M | +134.3% |
| Net Income | $1.29B |
| Line Item | 2024-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.33B | -16.4% |
| Accounts Receivable | $1.32B | +2.6% |
| Inventory | $972.0M | -5.7% |
| Current Assets | $3.96B | -5.4% |
| Total Assets | $11.85B | +10.1% |
| Current Liabilities | $1.90B | +18.2% |
| Long-term Debt | $3.35B | +22.3% |
| Line Item | 2024-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.75B | -1.2% |
| Capital Expenditures | $378.0M | +26.8% |
| Investing Cash Flow | -$1.26B | -305.8% |
| Financing Cash Flow | -$752.0M | +19.1% |
| Free Cash Flow | $1.37B | -6.9% |
| +4.0% |
| EPS (Basic) | $4.44 | +5.2% |
| EPS (Diluted) | $4.43 | +5.7% |
| Total Liabilities |
| $5.95B |
| +20.9% |
| Stockholders' Equity | $5.90B | +0.9% |